









Markets
/
Stocks
/
nasdaq-shc
/

Sotera Health Co

SHC

16.052USD

+0.002+0.01%

Market hours （ET）Quotes delayed by 15 min

4.56BMarket Cap

189.93P/E TTM



Sotera Health Co

16.052

+0.002+0.01%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score

Currency: USD Updated：2025-09-12

Key Insights

The company's fundamentals are relatively very healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite a very weak market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking

28 / 72

Overall Ranking

170 / 4724

Industry

Healthcare Providers & Services

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 7 analysts

Buy

Current Rating

16.400

Target Price

+2.18%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks

Sotera Health Company is a global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry. The Company’s segments include Sterigenics, Nordion, and Nelson Labs. The Sterigenics business provides outsourced terminal sterilization and irradiation services for the medical device, pharmaceutical, food safety and advanced applications markets using three technologies: gamma irradiation, ethylene oxide (EO) processing and E-beam irradiation. The Nordion business is a provider of Co-60 used in the sterilization and irradiation processes for the medical device, pharmaceutical, food safety, and materials industries and for the treatment of cancer. In addition, Nordion is a global provider of gamma irradiation systems. The Nelson Labs business provides outsourced microbiological and analytical chemistry testing and advisory services for the medical device and pharmaceutical industries.

Overvalued

The company’s latest PE is 189.16, at a high 3-year percentile range.

Institutional Selling

The latest institutional holdings are 278.88M shares, decreasing 4.63% quarter-over-quarter.

Held by The Vanguard

Star Investor The Vanguard holds 14.87M shares of this stock.

Higher Market Activity

The company has more investor interest, with a 20-day turnover ratio of 0.39.

Financial Health

Currency: USD Updated：2025-09-12

The company's current financial score is 6.85, which is lower than the Healthcare Providers & Services industry's average of 7.15. Its financial status is robust, and its operating efficiency is average. Its latest quarterly revenue reached 254.52M, representing a year-over-year increase of 2.56%, while its net profit experienced a year-over-year increase of 310.44%.

Score

Industry at a Glance

Previous score

6.85

Change



Financials

8.15

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

4.20

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

7.54

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

7.25

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

7.11

Key Metrics

Free cash flow

No Data

Company Valuation

Currency: USD Updated：2025-09-12

The company’s current valuation score is 3.60, which is higher than the Healthcare Providers & Services industry's average of 2.15. Its current P/E ratio is 194.46, which is -56.92% below the recent high of 83.77 and 106.42% above the recent low of -12.49.

Score

Industry at a Glance

Previous score

2.35

Change

-0.06

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 28/72

No Data

Earnings Forecast

Currency: USD Updated：2025-09-12

The company’s current earnings forecast score is 8.25, which is higher than the Healthcare Providers & Services industry's average of 7.66. The average price target for Sotera Health Co is 17.00, with a high of 17.00 and a low of 15.00.

Score

Industry at a Glance

Previous score

8.00

Change

Support & Resistance

No Data

Analyst Rating

Based on 7 analysts

Buy

Current Rating

16.400

Target Price

+2.18%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

Sotera Health Co

SHC

CVS Health Corp

CVS

HCA Healthcare Inc

HCA

Teladoc Health Inc

TDOC

Tenet Healthcare Corp

THC

Natera Inc

NTRA

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated：2025-09-12

The company’s current price momentum score is 9.75, which is higher than the Healthcare Providers & Services industry's average of 7.47. Sideways: Currently, the stock price is trading between the resistance level at 18.37 and the support level at 12.82, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.56

Change

-0.08

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(1)

Neutral(4)

Buy(2)

Indicators

Value

Direction

MACD(12,26,9)

-0.345

Neutral

RSI(14)

62.823

Neutral

STOCH(KDJ)(9,3,3)

67.834

Buy

ATR(14)

0.443

High Vlolatility

CCI(14)

17.331

Neutral

Williams %R

34.981

Buy

TRIX(12,20)

0.676

Sell

StochRSI(14)

68.922

Neutral

Moving Average

Sell(1)

Neutral(0)

Buy(5)

Indicators

Value

Direction

MA5

15.926

Buy

MA10

15.926

Buy

MA20

16.055

Sell

MA50

13.688

Buy

MA100

12.850

Buy

MA200

12.748

Buy

Institutional Confidence

Currency: USD Updated：2025-09-12

The company’s current institutional recognition score is 10.00, which is higher than the Healthcare Providers & Services industry's average of 7.19. The latest institutional shareholding proportion is 98.25%, representing a quarter-over-quarter decrease of 0.30%. The largest institutional shareholder is The Vanguard, holding a total of 14.87M shares, representing 5.24% of shares outstanding, with 0.37% decrease in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

Warburg Pincus LLC

73.82M

GTCR Golder Rauner, LLC

49.22M

Darsana Capital Partners LP

20.01M

The Vanguard Group, Inc.

Star Investors

14.86M

-0.18%

Sculptor Capital Management, Inc

9.04M

+80.75%

BlackRock Institutional Trust Company, N.A.

12.39M

+0.39%

T. Rowe Price Investment Management, Inc.

8.05M

+5.94%

Sachem Head Capital Management LP

7.91M

Sessa Capital

6.30M

Janus Henderson Investors

6.70M

-13.87%

Risk Assessment

Currency: USD Updated：2025-09-12

The company's beta value is 1.83. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.